Apokyn Injection
Product Images NDC 27505-004

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Apokyn (NDC 27505-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mdd Us Operations, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Apokyn 01)

Chemical structure of apomorphine hydrochloride monohydrate, showing the molecular arrangement of apomorphine with associated hydrochloride and water of hydration (HCl · 1/2 H2O).*

FDA Label Image

Figure 2 (Apokyn 02)

A line graph titled 'UPDRS Motor Scores' showing change from predose over time in minutes. It compares pooled APOKYN and placebo groups, with the vertical axis indicating change from predose and the horizontal axis representing time points up to 90 minutes. The APOKYN line shows a greater decrease in motor scores than placebo before partially returning toward baseline.*

FDA Label Image

Apokyn Pen (Apokyn 03)

APOKYN Pen injection device labeled with the proprietary name APOKYN™ PEN. The pen is designed for subcutaneous administration of Apomorphine Hydrochloride injection, 30 mg/3 mL. It is a handheld, pen-shaped device primarily gray with a teal adjustment dial and a measurement window, produced by MDD US Operations, LLC.*

FDA Label Image

Gray Pen Cap (Apokyn 04)

Packaging label of APOKYN 30 mg/3 mL subcutaneous injection showing a syringe filled with liquid, labeled with the imprint 'BD'. The label is from MDD US Operations, LLC and corresponds to the NDC 27505-004.*

FDA Label Image

Gray Pen Body (Apokyn 05)

APOKYN 30 mg/3 mL injection, subcutaneous dosage form, is shown in a clear glass vial with a white label. The vial has a black rubber stopper sealed by a metal cap with a blue flip-off seal. The label includes black and blue text and barcodes. The product is manufactured by MDD US Operations, LLC.*

FDA Label Image

Pen Needle Unit (Apokyn 06)

An instructional illustration showing four diagrammatic images labeled f, g, h, and i. These appear to depict parts or steps related to a subcutaneous injection device, possibly for APOKYN injection 30 mg/3 mL by MDD US Operations, LLC.*

FDA Label Image

Cartridge (Apokyn 07)

An illustration showing a syringe with labels 'j' and 'k' pointing to specific parts, likely indicating components or measurements relevant to the injection device.*

FDA Label Image

Teal Cartridge Holder (Apokyn 08)

An illustration of a single-dose injection pen for APOKYN (apomorphine hydrochloride) subcutaneous injection, 30 mg/3 mL. The image shows the device used to administer the medication, designed for subcutaneous use, distributed by MDD US Operations, LLC.*

FDA Label Image

Image (Apokyn 09)

An instructional illustration showing a hand holding a syringe and another hand holding a vial, with a crossed-out circle over the entire image, indicating an action not to perform with this injection.*

FDA Label Image

Apokyn 10a

An instructional illustration showing a close-up of a new needle tip, emphasizing its condition and readiness for use with an injection device.*

FDA Label Image

Apokyn 10b

An instructional illustration showing the tip of a needle with a diagonal line across it and the words 'Reused Needle' below, indicating the concept or warning related to needle reuse.*

FDA Label Image

Step 1 (Apokyn 11)

Instructional illustration showing a person holding a pen injector device, with the other hand removing or attaching the cap from the needle end of the device. The image is labeled with the number 1 in a green box, indicating a step in the injection preparation process.*

FDA Label Image

Step 2 (Apokyn 12)

An instructional illustration showing hands assembling or preparing a subcutaneous injection device, likely for APOKYN (apomorphine hydrochloride) injection. The image depicts attaching or securing a component such as a needle to the injection pen or syringe before use.*

FDA Label Image

Step 3 (Apokyn 13)

An instructional illustration showing a hand holding a syringe-like device while using the other hand to insert or attach a small component or needle. The top left corner includes a green box with the number 3, indicating a step in a multi-step process, likely related to preparing or administering the APOKYN injection.*

FDA Label Image

Step 4 (Apokyn 14)

An instructional illustration labeled with the number 4, showing a close-up of a hand holding a pen-like injection device. Another hand is removing or attaching a cap or cover from the device, indicating a step in the preparation or use of the APOKYN injection.*

FDA Label Image

Step 5 (Apokyn 15)

An instructional diagram showing a syringe with a red line mark indicating the 0.6 mL volume level. The syringe is part of the APOKYN (Apomorphine Hydrochloride) injection, 30 mg/3 mL, for subcutaneous use by MDD US Operations, LLC.*

FDA Label Image

Step 6 (Apokyn 16)

Instructional illustration showing hands preparing an APOKYN (apomorphine hydrochloride) injection, subcutaneous, 30 mg/3 mL, by removing a protective cap from the syringe prior to administration.*

FDA Label Image

Step 7 (Apokyn 17)

An instructional illustration showing a hand holding a syringe with a vial. The image depicts the steps to prepare the injection by attaching or removing the needle from the vial, indicated by directional arrows around the syringe and vial.*

FDA Label Image

Step 8 (Apokyn 18)

An instructional illustration showing a close-up of hands holding a syringe and a vial, preparing an injection. The image highlights the preparation of APOKYN injection, 30 mg/3 mL, subcutaneous use, from MDD US Operations, LLC.*

FDA Label Image

Step 9 (Apokyn 19)

An instructional illustration showing a hand holding a syringe designed for APOKYN (apomorphine hydrochloride) 30 mg/3 mL subcutaneous injection. The image appears to demonstrate a step in preparing or administering the injection, focusing on the syringe and needle.*

FDA Label Image

Step 10 (Apokyn 20)

This illustration depicts two detailed instructional steps for APOKYN (apomorphine hydrochloride) injection. Image 10a shows a hand removing a cap from a vial or cartridge, exposing the rubber stopper. Image 10b presents a close-up of the vial or cartridge top with a label, highlighting preparation for administration.*

FDA Label Image

Step 11 (Apokyn 21)

An instructional illustration showing the steps to prepare a subcutaneous injection of APOKYN (Apomorphine Hydrochloride) 30 mg/3 mL. The image depicts hands twisting and assembling parts of an injection device, likely focusing on the cartridge and plunger mechanism, as part of the medication preparation process.*

FDA Label Image

Step 12 (Apokyn 22)

An instructional illustration showing a hand holding a syringe, with the needle positioned near a fingertip, demonstrating the subcutaneous injection technique for APOKYN (apomorphine hydrochloride injection). The image indicates proper handling and injection site preparation for this medication.*

FDA Label Image

Step 13 (Apokyn 23)

An instructional illustration showing a hand holding a device with a thumb pressing a button or cap at the top. The image likely demonstrates a step in using a medical injection device, relevant to APOKYN injection.*

FDA Label Image

Step 14 (Apokyn 24)

An instructional illustration depicts a hand holding an injection pen or syringe poised to engage or insert into a vial or cartridge set in a tray, likely demonstrating a step in preparing APOKYN injection (apomorphine hydrochloride) for subcutaneous use. The image is marked with the number 14 in a green square at the top left corner.*

FDA Label Image

Step 15 (Apokyn 25)

An instructional illustration showing a hand removing the cap from a vial with a labeled number '15' in the upper left corner, indicating a step in the preparation or administration process of APOKYN (apomorphine hydrochloride) injection.*

FDA Label Image

Principal Display Panel (30 mg/3 mL Cartridge Carton)

APOKYN (apomorphine hydrochloride injection) 30 mg/3 mL (10 mg/mL) carton label for subcutaneous injection cartridges. The package contains 5 cartridges for single-patient use with an APOKYN Pen injector. Manufactured by Vetter Pharma-Fertigung GmbH and distributed by US WorldMeds, the label includes storage instructions and a warning about sulfites.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.